Skip to main content

Broad Institute and Genetix, GeneGo and NIEHS, Sigma-Aldrich and Corning Life Sciences, PerkinElmer and Becton Dickinson


Broad Buys Ninth Colony Picking System from Genetix

The Broad Institute has chosen the Genetix QPix2XT colony picking system to help it standardize its genome sequencing operations, the company said last week.

The Institute now owns nine Genetix QPix2XT instruments and has installed them in its sequencing laboratory, the company said.

Financial terms of the agreement were not disclosed.

GeneGo Gets $100K SBIR Grant from NIEHS to Analyze Networks from Toxicogenomics Data

GeneGo has received a Phase I SBIR grant from the National Institute of Environmental Health Sciences to analyze cellular signaling networks activated in response to drugs and toxins, the St. Joseph, Mich.-based company said last week.

The company did not list the amount of the grant, but according to an NIH database, GeneGo received a $98,648 grant from NIEHS this month for a 6-month project, entitled "Networks From Toxicogenomics Gene Expression Data."

In the first phase of the project, GeneGo will re-analyze publicly available data using its MetaCore platform.

Sigma-Aldrich to Distribute Corning's Plastic Lab Products

Sigma-Aldrich and Corning Life Sciences announced a pact last week to offer a more streamlined distribution channel for Corning's customers.

According to the partners, US customers will be able to place orders through Sigma-Aldrich for virtually all of Corning's plastic lab products, as well as its Pyrex glassware line. The distribution system will use Corning's own product numbering system.

PerkinElmer, BD Declare Dividends

PerkinElmer's board last week agreed to issue a $.07 dividend to existing shareholders on Aug. 12. The dividend applies to all shareholders of all record at the close of business on July 22, the company said.

Meanwhile, Becton Dickinson's board declared a quarterly dividend of $.18 per share. The dividend will be paid on June 30 to shareholders of record on June 9.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.